Home > Boards > US OTC > Biotechs > Titan Pharmaceuticals Inc. (TTNP)

JK----you forgot to mention that 17 cents this

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
rikshot Member Profile
 
Followed By 3
Posts 540
Boards Moderated 0
Alias Born 08/06/15
160x600 placeholder
Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire (US) - 11/7/2019 4:30:00 PM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 11/4/2019 6:03:29 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 10/22/2019 9:56:11 AM
Titan Pharmaceuticals To Present Two Posters On Probuphine® At The 10th American Conference On Pharmacometrics PR Newswire (US) - 10/22/2019 8:00:00 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 10/18/2019 4:33:31 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 10/17/2019 1:19:14 PM
Notice of Effectiveness (effect) Edgar (US Regulatory) - 10/17/2019 6:01:01 AM
Titan Pharmaceuticals Announces Pricing Of $9.0 Million Underwritten Public Offering PR Newswire (US) - 10/16/2019 9:20:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/11/2019 1:44:48 PM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 10/8/2019 5:29:00 PM
Titan Pharmaceuticals and Crossroads of Southern Nevada Announce Probuphine® Availability at Crossroads Rehabilitation Facil... PR Newswire (US) - 10/1/2019 8:00:00 AM
Securities Registration Statement (s-1/a) Edgar (US Regulatory) - 9/30/2019 6:02:47 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/20/2019 11:30:58 AM
Confidential Treatment Order (ct Order) Edgar (US Regulatory) - 9/20/2019 9:46:58 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 9/18/2019 5:30:49 PM
Titan Receives Approval For Second Year Of NIDA Grant Funding For Development Of A Nalmefene Implant PR Newswire (US) - 9/18/2019 8:00:00 AM
Securities Registration Statement (s-1) Edgar (US Regulatory) - 9/12/2019 9:29:19 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 8/23/2019 11:36:37 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 8/19/2019 5:27:56 PM
Quarterly Report (10-q) Edgar (US Regulatory) - 8/14/2019 4:13:56 PM
Titan Pharmaceuticals Reports Second Quarter 2019 Financial Results PR Newswire (US) - 8/14/2019 4:03:00 PM
Titan Pharmaceuticals To Release Second Quarter 2019 Financial Results On August 14 - Conference Call To Follow PR Newswire (US) - 8/9/2019 5:00:00 PM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 8/7/2019 12:46:16 PM
Titan Pharmaceuticals Announces Pricing Of $2.1 Million Registered Direct Offering PR Newswire (US) - 8/7/2019 9:15:00 AM
Titan Pharmaceuticals Expands Patient Access To Probuphine® Via Specialty Product Distribution Agreement With CVS Caremark PR Newswire (US) - 7/9/2019 9:00:00 AM
rikshot   Wednesday, 10/16/19 12:34:22 PM
Re: Jkings post# 14907
Post # of 15038 
JK----you forgot to mention that 17 cents this morning is "Such a Deal". Joe Biden recently said you can get "coupons" to get good deals in the stock market. If these "come lately" TTNP buyers would check newspapers, magazines, and internet ads, they could find "coupons" that could make TTNP stock a real "treasure"at this time. Many thanks to "Good Old Joe". I respect JK's insight & presence on this msg bd.


PS---JK: You've got to be VERRRRRY careful how you "word" things these days.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist